Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Preferred Dividend Payments (2018 - 2021)

Historic Preferred Dividend Payments for Surgery Partners (SGRY) over the last 4 years, with Q1 2021 value amounting to $10.3 million.

  • Surgery Partners' Preferred Dividend Payments rose 842.11% to $10.3 million in Q1 2021 from the same period last year, while for Dec 2021 it was $10.3 million, marking a year-over-year decrease of 7392.41%. This contributed to the annual value of $10.3 million for FY2021, which is 7392.41% down from last year.
  • Per Surgery Partners' latest filing, its Preferred Dividend Payments stood at $10.3 million for Q1 2021, which was up 842.11% from $10.3 million recorded in Q4 2020.
  • Surgery Partners' Preferred Dividend Payments' 5-year high stood at $32.4 million during Q4 2018, with a 5-year trough of $7.8 million in Q1 2018.
  • Its 4-year average for Preferred Dividend Payments is $10.9 million, with a median of $9.3 million in 2019.
  • As far as peak fluctuations go, Surgery Partners' Preferred Dividend Payments plummeted by 7129.63% in 2019, and later soared by 1176.47% in 2020.
  • Quarter analysis of 4 years shows Surgery Partners' Preferred Dividend Payments stood at $32.4 million in 2018, then crashed by 71.3% to $9.3 million in 2019, then grew by 10.75% to $10.3 million in 2020, then changed by 0.0% to $10.3 million in 2021.
  • Its last three reported values are $10.3 million in Q1 2021, $10.3 million for Q4 2020, and $10.0 million during Q3 2020.